These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10774640)

  • 21. An extremely high bioavailability of orally administered vancomycin in a patient with severe colitis and renal insufficiency.
    Yamazaki S; Suzuki T; Suzuki T; Takatsuka H; Ishikawa M; Hattori N; Fujishiro T; Miyauchi H; Oami T; Ariyoshi N; Oda S; Matsubara H; Ishii I
    J Infect Chemother; 2017 Dec; 23(12):848-851. PubMed ID: 28923303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature.
    Apisarnthanarak A; Razavi B; Mundy LM
    Clin Infect Dis; 2002 Sep; 35(6):690-6. PubMed ID: 12203166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin dosing and monitoring.
    Med Lett Drugs Ther; 2009 Apr; 51(1309):25. PubMed ID: 19343006
    [No Abstract]   [Full Text] [Related]  

  • 24. Why monitor peak vancomycin concentrations?
    Wysocki M; Thomas F; Wolff M
    Lancet; 1995 Mar; 345(8950):646; author reply 646-7. PubMed ID: 7898194
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibiotic-associated colitis treated with oral vancomycin.
    Saadah HA; Esaki PE
    J Okla State Med Assoc; 1979 Dec; 72(12):428-9. PubMed ID: 521859
    [No Abstract]   [Full Text] [Related]  

  • 26. Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin.
    Chang TW; Gorbach SL; Bartlett JG; Saginur R
    Gastroenterology; 1980 Jun; 78(6):1584-6. PubMed ID: 7372074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why monitor peak vancomycin concentrations?
    MacGowan A; Lovering A; White L; Reeves D
    Lancet; 1995 Mar; 345(8950):645; author reply 646-7. PubMed ID: 7898191
    [No Abstract]   [Full Text] [Related]  

  • 28. Staphylococcic (pseudomembranous) enterocolitis.
    Hall WH; Khan MY
    Minn Med; 1966 Jun; 49(6):929-31. PubMed ID: 5933707
    [No Abstract]   [Full Text] [Related]  

  • 29. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.
    Bartlett JG; Tedesco FJ; Shull S; Lowe B; Chang T
    Gastroenterology; 1980 Mar; 78(3):431-4. PubMed ID: 7053190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin removal by plasmapheresis.
    Osman BA; Lew SQ
    Pharmacol Toxicol; 1997 Nov; 81(5):245-6. PubMed ID: 9396092
    [No Abstract]   [Full Text] [Related]  

  • 31. Vancomycin: a reappraisal.
    Brown R; Wise R
    Br Med J (Clin Res Ed); 1982 May; 284(6328):1508-9. PubMed ID: 6805584
    [No Abstract]   [Full Text] [Related]  

  • 32. Why monitor peak vancomycin concentrations?
    de Hoog M; Mouton JW; van den Anker JN
    Lancet; 1995 Mar; 345(8950):646; author reply 646-7. PubMed ID: 7898192
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibiotic-associated colitis.
    Bartlett JG
    Clin Gastroenterol; 1979 Sep; 8(3):783-801. PubMed ID: 387304
    [No Abstract]   [Full Text] [Related]  

  • 34. [Relapsing infections with Clostridium difficile].
    Visser WE; Dingemans-Dumas AM; Bac DJ
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vancomycin and novobiocin.
    Riley HD
    Med Clin North Am; 1970 Sep; 54(5):1277-89. PubMed ID: 4248512
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of pseudomembranous colitis and antibiotic-associated diarrhoea.
    Burdon DW
    J Antimicrob Chemother; 1984 Dec; 14 Suppl D():103-9. PubMed ID: 6394575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infectious disease threats: what are we to do? Preface.
    Paauw DS
    Med Clin North Am; 2013 Jul; 97(4):xiii-xiv. PubMed ID: 23809724
    [No Abstract]   [Full Text] [Related]  

  • 38. Pseudomembranous colitis and bacteremia in an immune competent patient associated with a rare specie of Clostridium (C. ramosum).
    Alcalde-Vargas A; Trigo-Salado C; Leo Carnerero E; De-la-Cruz-Ramírez D; Herrera-Justiniano JM
    Rev Esp Enferm Dig; 2012 Sep; 104(9):498-9. PubMed ID: 23130861
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pseudomembranous colitis probably caused by Clostridium difficile: first case appeared during preventive treatment of infection of ascitic fluid with norfloxacin].
    Tordjman R; Benfiguig K; Eugène C; Mitry E; Merrer J
    Gastroenterol Clin Biol; 1995 May; 19(5):545-6. PubMed ID: 7590012
    [No Abstract]   [Full Text] [Related]  

  • 40. Decompressive colonoscopy with intracolonic vancomycin administration for the treatment of severe pseudomembranous colitis.
    Shetler K; Nieuwenhuis R; Wren SM; Triadafilopoulos G
    Surg Endosc; 2001 Jul; 15(7):653-9. PubMed ID: 11591962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.